Literature DB >> 18279029

Paraoxonase 1: genetics and activities during aging.

Francesca Marchegiani1, Maurizio Marra, Fabiola Olivieri, Maurizio Cardelli, Richard W James, Massimo Boemi, Claudio Franceschi.   

Abstract

The increasing longevity of the population, one of the most important issues throughout the planet, is a very complex phenomenon (trait), likely resulting from a variety of environmental determinants interacting with and modulated by genetic mechanisms, mostly devoted to maintenance and repair. In fact, the genes involved in longevity impact upon basic processes such as inflammation, glucose and energy utilization, and oxidative stress. Based on the free radical theory of aging, in the past few years we have focused our attention on an enzyme that protects lipids from peroxidative damage-paraoxonase 1 (PON1). PON1 has been widely investigated, especially for its involvement in atherosclerosis and age-related diseases. In this review, we summarize data on the role played by PON1 on aging and its possible involvement in human longevity, focusing on the relationship between genetic polymorphisms and enzyme activity and its capability to counteract oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18279029     DOI: 10.1089/rej.2007.0582

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  7 in total

Review 1.  A review of pharmacogenetics of adverse drug reactions in elderly people.

Authors:  Maurizio Cardelli; Francesca Marchegiani; Andrea Corsonello; Fabrizia Lattanzio; Mauro Provinciali
Journal:  Drug Saf       Date:  2012-01       Impact factor: 5.606

2.  Protective effect of paraoxonase 1 gene variant Gln192Arg in age-related macular degeneration.

Authors:  Gayle J T Pauer; Gwen M Sturgill; Neal S Peachey; Stephanie A Hagstrom
Journal:  Am J Ophthalmol       Date:  2009-12-30       Impact factor: 5.258

Review 3.  Immune and inflammatory mechanisms of atherosclerosis (*).

Authors:  Elena Galkina; Klaus Ley
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

4.  Paraoxonase-1 55 LL Genotype Is Associated with No ST-Elevation Myocardial Infarction and with High Levels of Myoglobin.

Authors:  Francesca Marchegiani; Liana Spazzafumo; Maurizio Cardelli; Mauro Provinciali; Francesco Lescai; Claudio Franceschi; Roberto Antonicelli
Journal:  J Lipids       Date:  2012-03-25

5.  Paraoxonase-1 (PON1) rs662 Polymorphism and Its Association with Serum Lipid Levels and Longevity in the Bama Zhuang Population.

Authors:  You Li; Guiyun Liang; Liwei Shi; Xue Liang; Bingshuang Long; Jian Qin; Zhiyong Zhang
Journal:  Med Sci Monit       Date:  2016-12-27

6.  Validation of PON1 enzyme activity assays for longitudinal studies.

Authors:  Karen Huen; Rebecca Richter; Clement Furlong; Brenda Eskenazi; Nina Holland
Journal:  Clin Chim Acta       Date:  2008-12-24       Impact factor: 3.786

7.  Paraoxonase 1 activity and phenotype distribution in premenopausal and postmenopausal women.

Authors:  Dražan Butorac; Ivana Celap; Sanja Kačkov; Vera Robić; Tomislav Miletić; Zlata Flegar Meštrić; Andrea Hulina; Krunoslav Kuna; Tihana Žanić Grubišić; Marija Grdić Rajković
Journal:  Biochem Med (Zagreb)       Date:  2014-06-15       Impact factor: 2.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.